Achieve Life Sciences amends technology license agreement with University of Bristol Jan. 25, 2018 No Comments
FDA issues complete response letter for CAM-2038 NDA for opioid use disorder Jan. 22, 2018 No Comments
Addex and Indivior sign licensing and collaboration agreement for ADX-71441 to treat addiction Jan. 3, 2018 No Comments
Axsome Therapeutics and Duke University to collaborate on phase II study of AXS-05 Dec. 15, 2017 No Comments
OX1 receptor antagonist C4X_3256 demonstrates efficacy in nicotine dependence rat model Nov. 15, 2017 No Comments
RSS